Peripartum cardiomyopathy.
In 1971, Demakis and colleagues established the term peripartum cardiomyopathy (PPCM) and defined it by criteria based on the clinical profile of their patients. With the recognition that these criteria are arbitrary and that PPCM often presents earlier in pregnancy, the definition of PPCM has been recently updated by a working group on PPCM of the European Society of Cardiology. This article discusses the cause, clinical presentation, prognosis, and treatment of PPCM, as well as other related topics.
Division of Cardiology, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. elkayam@usc.edu
Uri
U
Elkayam
Sawan
S
Jalnapurkar
Mohamad
M
Barakat
D015415:Biomarkers; D009202:Cardiomyopathies / Q000628:therapy*; D017147:Defibrillators, Implantable; D036861:Delivery, Obstetric / Q000379:methods; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D016027:Heart Transplantation / Q000379:methods; D006353:Heart-Assist Devices; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy*; D011256:Pregnancy Outcome; D011379:Prognosis; D020127:Recovery of Function; D012307:Risk Factors; D035703:Therapies, Investigational
D015415:Biomarkers